Barry Ticho - Aug 14, 2025 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Jonathan Allan, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
Aug 14, 2025
Transactions value $
$0
Form type
4
Date filed
8/18/2025, 08:25 PM
Previous filing
Aug 5, 2025
Next filing
Aug 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ticho Barry CHIEF MEDICAL OFFICER C/O STOKE THERAPEUTICS, INC., 45 WIGGINS AVENUE, BEDFORD /s/ Jonathan Allan, Attorney-in-Fact 2025-08-18 0001780088

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STOK Common Stock Options Exercise $0 +10K +59.61% $0.00 26.8K Aug 14, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Performance Stock Units Award $0 +20K $0.00 20K Aug 14, 2025 Common Stock 20K Direct F1, F2, F3
transaction STOK Performance Stock Units Options Exercise $0 -10K -50% $0.00 10K Aug 14, 2025 Common Stock 10K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance stock unit represents a right to receive one share of the Issuer's common stock.
F2 This award represents a grant of restricted stock units upon the achievement of certain performance criteria as certified by the Issuer's compensation committee on the Transaction Date.
F3 Half the award vests on August 14, 2025 and the remainder shall vest on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date.